Patents Assigned to SMSBIOTECH, INC.
  • Patent number: 12146164
    Abstract: Disclosed herein are small mobile stem (SMS) cells and methods of culturing, isolating, and using SMS cells. Also disclosed are methods of culturing SMS cells in an undifferentiated state for prolonged periods of time, and for using SMS cells for the production of a variety of molecules, including proteins, extracellular matrix (ECM) proteins, and the use of SMS cells in microfluidic devices.
    Type: Grant
    Filed: March 27, 2017
    Date of Patent: November 19, 2024
    Assignee: SMSbiotech, Inc.
    Inventor: Abdulkader Rahmo
  • Patent number: 11345886
    Abstract: The presently disclosed subject matter relates, in general, to the identification, isolation, and use of a population of stem cells isolated from umbilical cord blood, peripheral blood and/or other sources and that are referred to herein as Small Mobile Stem cells (short: SMS). More particularly, the presently disclosed subject matter relates to isolating said SMS stem cells and employing the same, optionally after in vitro manipulation, to treat tissue and/or organ damage in a subject in need thereof.
    Type: Grant
    Filed: July 18, 2018
    Date of Patent: May 31, 2022
    Assignee: SMSBIOTECH, INC.
    Inventor: Abdulkader Rahmo
  • Patent number: 10041037
    Abstract: The presently disclosed subject matter relates, in general, to the identification, isolation, and use of a population of stem cells isolated from umbilical cord blood, peripheral blood and/or other sources and that are referred to herein as Small Mobile Stem cells (short: SMS). More particularly, the presently disclosed subject matter relates to isolating said SMS stem cells and employing the same, optionally after in vitro manipulation, to treat tissue and/or organ damage in a subject in need thereof.
    Type: Grant
    Filed: June 9, 2014
    Date of Patent: August 7, 2018
    Assignee: SMSBIOTECH, INC.
    Inventor: Abdulkader Rahmo